The SPR-based biosensor test system for analysis of small compounds interaction with human cytochrome P450 51A1 (CYP51A1)

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry

Volumn 7, Issue 3, 2013, Pages 187-195

  Gnedenko, O V ^a   Kaluzhskiy, L A ^a   Molnar, A A ^a   Yantsevich, A V ^b   Mukha, D V ^b   Gilep, A A ^b   Usanov, S A ^b   Stonik, V A ^c   Ivanov, A S ^a   Lisitsa, A V ^a   Archakov, A I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

^c PACIFIC INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

atherosclerosis; azoles; CYP51A1 inhibitors; human cytochrome P450 51A1 (CYP51A1); interaction screening; SPR based test system assay

Indexed keywords

3BETA,6BETA DIHYDROXY 5ALPHA CHOLESTANE; BETULAFOLIENTRIOL; BETULIN BIS GLUCOSIDE; BETULIN GLUCOSIDE; BETULIN MALTOSIDE; CAULOSIDE C; CAULOSIDE D; CHOLESTEROL MALTOSIDE; CYTOCHROME P450; CYTOCHROME P450 51A1; DIGITONIN; DOCONAZOLE; HEDERAGENIN; HOLOTURIN A; ITRACONAZOLE; KETOCONAZOLE; LIAROZOLE; LORECLEZOLE; PARCONAZOLE; PENCONAZOLE; PYRROLE DERIVATIVE; RIDOGREL; SITOGLUSIDE; STEROID; STICHOPOSIDE; STICHOPOSIDE A; STICHOPOSIDE C; TEASAPONIN; TRITERPENE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BINDING AFFINITY; BIOSENSOR; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SELECTIVITY; ENZYME IMMOBILIZATION; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; VALIDATION STUDY;

EID: 84884558025     PISSN: 19907508     EISSN: 19907516     Source Type: Journal    
DOI: 10.1134/S1990750813030049     Document Type: Article

References (17)

1. Taylor, F., Ward, K., Moore, T.H., Burke, M., Davey Smith, G., Casas, J.P., and Ebrahim, S. Cochrane Database Syst. Rev., 2011, vol. 1, CD004816.
2. Baker, S.K., Muscle Nerve, 2005, vol. 31, pp. 572-580.
3. Korošec, T., Ačimovič, J., Seliškar, M., Kocjan, D., Fon Tacer, K., Rozman, D., and Urleb, U., Bioorg. Med. Chem., 2008, vol. 16, pp. 209-221.
4. Lamb, D.C., Kelly, D.E, and Kelly, S.L., FEBS Lett., 1998, vol. 425, pp. 263-265.
5. Strushkevich, N., Usanov, S.A., and Park, H.-W., J. Mol. Biol., 2010, vol. 397, pp. 1067-1078.
6. Mukha, D.V., Feranchuk, S.I., Gilep, A.A., and Usanov, S.A., Biochemistry (Moscow), 2011, vol. 76, pp. 175-185.
7. Bellamine, A., Mangla, A.T., Nes, W.D., and Waterman, M.R., Proc. Natl. Acad. Sci. USA, 1999, vol. 96, pp. 8937-8942.
8. Markgren, P.-O., Hamalainen, M., and Danielson, H., Analytical Biochemistry, 1998, vol. 265, pp. 340-350.
9. Ivanov, A.S., Gnedenko, O.V., Molnar, A.A., Mezentsev, Yu.V., Lisitsa, A.V., and Archakov, A.I., J. Bioinformatics and Computational Biology, 2007, vol. 5, pp. 579-592.
10. Ivanov, A.S., Gnedenko, O.V., Molnar, A.A., Archakov, A.I., and Podust, L.M., ACS Chemical Biology, 2010, vol. 5, pp. 767-776.
11. Ershov, P.V., Gnedenko, O.V., Molnar, A.A., Lisitsa, A.V., Ivanov, A.S., and Archakov, A.I., Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2009, vol. 3, pp. 272-288.
12. Pearson, J.T., Hill, J.J., Swank, J., Isoherranen, N., Kunze, K.L., and Atkins, W.M., Biochemistry, 2006, vol. 45, pp. 6341-6353.
13. Van Wauwe, J., Van Nyen, G., Coene, M.C., Stoppie, P., Cools, W., Goossens, J., Borghgraef, P., and Janssen, P.A., J. Pharmacol. Exp. Ther., 1992, vol. 261, pp. 773-779.
14. Parker, J.E., Merkamm, M., Manning, N.J., Pompon, D., Kelly, S.L., and Kelly, D.E., Antimicrob. Agents Chemother., 2008, vol. 52, pp. 3597-3603.
15. Warrilow, A.G.S., Martel, C.M., Parker, J.E., Melo, N., Lamb, D.C., Nes, W.D., Kelly, D.E., and Kelly, S.L., Antimicrob. Agents Chemother., 2010, vol. 54, pp. 4235-4245.
16. Biacore Sensor Surface Handbook, 2003, p. 35.
17. Majka, J. and Speck, C., Adv. Biochem. Eng. Biotechnol., 2007, vol. 104, pp. 13-36.